DOI:
10.1055/s-00000167
International Journal of Angiology
LinksClose Window
References
Liu HR, Tao L, Gao E , et al.
Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation—a novel mechanism for the cardioprotective effects of PPAR agonists.
Cardiovasc Res 2009;
81 (2) 344-352
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.